Thursday’s Full Approval of Alzheimer’s Drug Leqembi
Thursday marked the anticipated full approval of the Alzheimer’s disease drug Leqembi. Although this news was expected, it has resulted in some investors choosing to sell. Biogen stock (BIIB) experienced…